Drugs / Breztri Aerosphere
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | BREZTRI AEROSPHERE | — | 2020-07-23 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05472350 | Aug 2022 → Aug 2023 | non-small cell lung carcinoma, poisoning | Jianxing He | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Breztri Aerosphere | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05472350 ↗ |
| Route | Inhaled | “co-suspension metered dose inhaler” PMID 40386713 ↗ Apr 2025 |